#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vulval cancer Rosai-Dorfman syndrome Adenoid cystic carcinoma Spinal cord injury cervical Keratosis follicular Waldenstrom's macroglobulinaemia Pyruvate kinase deficiency anaemia Fallopian tube cancer Glycogen storage disease type V Thyroid cancer metastatic Friedreich's ataxia B-cell lymphoma recurrent Thrombotic thrombocytopenic purpura White matter lesion Ovarian cancer stage IV More trials…

    Learn about Rare Diseases

    Choroid melanoma – Trials in Disease Fragile X syndrome – Life with Disease Medulloblastoma Prolymphocytic leukaemia – Life with Disease Basal cell naevus syndrome – Treatment Alexander disease Prolymphocytic leukaemia – Basic Information Focal segmental glomerulosclerosis – Basic Information Myxofibrosarcoma – Life with Disease Advanced systemic mastocytosis – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    SODIUM SELENITE PENTAHYDRATE Sacituzumab Govitecan Tinlarebant Brimonidine Tartrate Obicetrapib Anhydrous Benzoyl Peroxide IADADEMSTAT [11C]Az14193391 Calcium Polystyrene Sulfonate Water For Injections Dabrafenib Allo-647 Elacestrant LVT-001 Flupentixol Decanoate Leuprorelin Betamethasone Sodium Phosphate Satralizumab Nitrous Oxide Regn7257 More therapies…

    Learn about Your Condition

    Coronary artery disease Autoimmune haemolytic anaemia Chondrocalcinosis Cardiac valve disease Metastatic malignant melanoma IgA nephropathy Wheezing Pneumothorax Foetal growth restriction Neuroendocrine tumour Skin cancer Muscle hypertrophy Mantle cell lymphoma stage III Metastases to peritoneum Von Willebrand's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Safety and Tolerability of Alisertib Sodium and Paclitaxel in Patients with Small Cell Lung Cancer (Phase 2 Study)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Alisertib Sodium
    • Paclitaxel
    France Poland Spain

  • Ticagrelor, Acetylsalicylic Acid and Prasugrel in Patients with Acute Coronary Syndrome: A Study of Antiplatelet Management

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dipyridamole
    • Prasugrel Hydrobromide
    • Ticagrelor
    Norway Spain

  • Phase Ib/II study of momelotinib with nivolumab or pembrolizumab in unresectable stage III/IV cutaneous melanoma

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • Malignant melanoma stage III
    • Malignant melanoma stage IV
    Investigated Drugs:
    • Nivolumab
    • Pembrolizumab
    Sweden

  • Efficacy and Safety of Daily Subcutaneous Elamipretide Trihydrochloride Injections in Patients with Barth Syndrome (Phase 3b/4 Randomized Trial)

    Not yet recruiting

    3 1
    Investigated Drugs:
    • Elamipretide Trihydrochloride
    France Ireland Italy The Netherlands

  • Safety and feasibility study of CARCIK‑CD123/33 cell therapy in adult and pediatric patients with relapsed or refractory AML and BPDCN

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Blastic plasmacytoid dendritic cell neoplasia
    • Acute myeloid leukaemia
    Italy

  • Intrapleural Alteplase and Dornase Alfa versus VATS for Patients with Pleural Empyema (Parapneumonic Pleural Infection)

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Dornase Alfa
    • Alteplase
    The Netherlands
Previous Page
1 … 672 673 674 675 676 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!